139 related articles for article (PubMed ID: 3752754)
1. Flecainide in the treatment of nonsustained ventricular tachycardia.
Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
[TBL] [Abstract][Full Text] [Related]
2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
3. Flecainide: long-term treatment using a reduced dosing schedule.
Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
[TBL] [Abstract][Full Text] [Related]
4. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous and oral flecainide on ventricular tachycardia.
Ward DE; Cheesman M; Dancy M
Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
Breithardt G; Borggrefe M; Yeh HL; Seipel L
Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
[TBL] [Abstract][Full Text] [Related]
8. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
Anderson JL
Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820
[TBL] [Abstract][Full Text] [Related]
9. Oral flecainide for suppression of ventricular arrhythmias.
Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
[TBL] [Abstract][Full Text] [Related]
10. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
11. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death.
Reid PR; Griffith LS; Platia EV; Ord SE
Am J Cardiol; 1984 Feb; 53(5):108B-111B. PubMed ID: 6695814
[TBL] [Abstract][Full Text] [Related]
13. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
Salerno DM; Hodges M; Granrud G; Sharkey P
Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias.
Lal R; Chapman PD; Naccarrelli GV; Troup PJ; Rinkenberger RL; Dougherty AH; Ruffy R
J Am Coll Cardiol; 1985 Oct; 6(4):772-9. PubMed ID: 3928725
[TBL] [Abstract][Full Text] [Related]
15. Sinusoidal ventricular tachycardia associated with flecainide acetate.
Sellers TD; DiMarco JP
Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
[TBL] [Abstract][Full Text] [Related]
16. Effects of flecainide on ventricular function: clinical and experimental correlations.
Josephson MA; Ikeda N; Singh BN
Am J Cardiol; 1984 Feb; 53(5):95B-100B. PubMed ID: 6695822
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
Muhiddin KA; Turner P; Hellestrand K; Camm AJ
Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
[TBL] [Abstract][Full Text] [Related]
18. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
Hoffmann A; Wenk M; Follath F
Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
[TBL] [Abstract][Full Text] [Related]
19. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.
Morganroth J; Anderson JL; Gentzkow GD
J Am Coll Cardiol; 1986 Sep; 8(3):607-15. PubMed ID: 3745706
[TBL] [Abstract][Full Text] [Related]
20. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
Ward DE; Jones S; Shinebourne EA
Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
